Ocera Therapeutics, Inc. Shareholders' Equity
Ocera Therapeutics, Inc. had Shareholders' Equity of $3.85 million as of 2017-09-30, per its 10-Q filed 2017-11-14.
Discontinued › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2017-11-14
- 2017-09-30: Stockholders' Equity Attributable to Parent $3.85M.
- 2017-06-30: Stockholders' Equity Attributable to Parent $9.27M.
- 2017-03-31: Stockholders' Equity Attributable to Parent $13.52M.
- 2016-12-31: Stockholders' Equity Attributable to Parent $15.74M.
| Period end | Stockholders' Equity Attributable to Parent |
|---|---|
| 2017-09-30 | $3.85M 10-Q · filed 2017-11-14 |
| 2017-06-30 | $9.27M 10-Q · filed 2017-08-01 |
| 2017-03-31 | $13.52M 10-Q · filed 2017-05-09 |
| 2016-12-31 | $15.74M 10-Q · filed 2017-11-14 |
| 2016-09-30 | $18.85M 10-Q · filed 2016-11-02 |
| 2016-06-30 | $21.94M 10-Q · filed 2016-08-04 |
| 2016-03-31 | $26.71M 10-Q · filed 2016-05-03 |
| 2015-12-31 | $31.39M 10-K · filed 2017-03-14 |
| 2015-09-30 | $36.36M 10-Q · filed 2015-11-05 |
| 2015-06-30 | $39.60M 10-Q · filed 2015-08-10 |
| 2015-03-31 | $44.49M 10-Q · filed 2015-05-07 |
| 2014-12-31 | $50.15M 10-K · filed 2017-03-14 |
| 2014-09-30 | $54.72M 10-Q · filed 2014-11-13 |
| 2014-06-30 | $36.49M 10-Q · filed 2014-08-13 |
| 2014-03-31 | $42.84M 10-Q · filed 2014-05-13 |
| 2013-12-31 | $45.13M 10-K · filed 2017-03-14 |
| 2012-12-31 | -$62.81M 10-K · filed 2016-03-11 |
| 2011-12-31 | -$59.56M 10-K · filed 2014-03-18 |
| 2010-12-31 | -$55.05M 10-K · filed 2014-03-18 |
| 2009-12-31 | -$45.66M 10-K · filed 2014-03-18 |
| 2008-12-31 | -$32.62M 10-K · filed 2014-03-18 |
| 2007-12-31 | -$23.10M 10-K · filed 2014-03-18 |
| 2006-12-31 | -$10.93M 10-K · filed 2014-03-18 |
| 2005-12-31 | -$3.48M 10-K · filed 2014-03-18 |
| 2004-12-31 | -$39.00K 10-K · filed 2014-03-18 |
| 2004-12-19 | $0.00 10-K · filed 2014-03-18 |